doi: 10.1007/s13300020-009810 71 Marn-PealverJJMartn-TimnISevillano-CollantesCCaizo-GmezFJD
Avoid loose, unpackaged, or unlabeled edibles
an exceptionally high withdrawal rate was observed with once-weekly exenatide (43%), possibly related to the less comfortable pen injection device requiring resuspension of the active ingredient in buffer (Figure 3) or the occurrence of subcutaneous nodules at injection sites [175]
Managing the Experience: Side Effects and Support Since the approval of tirzepatide in 2022 and Zepbound in 2023, medical professionals have learned a great deal about managing the patient experience
Paediatr Child Health 6(6):329335 Azari AA, Barney NP (2013) Conjunctivitis: a systematic review of diagnosis and treatment
Ju, Carbon nanotubes reinforced with natural/synthetic polymers to mimic the extracellular matrices of bonea review